Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Gain/(Loss)	$ (388,561)	$ (659,473)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation and amortization	38,271	38,271
Loan acquisition costs	0	24,900
Gain on reduction of loan default penalty	(9,900)	0
Interest on notes payable	0	27,446
Debt discount		(205,000)
Amortization of debt discount	39,414	568,985
Derivative liability	44,684	(312,622)
Changes in operating assets and liabilities:
Accounts payable	174,935	205,025
Accrued Liabilities	105,435	110,340
Net cash used in operating activities	4,278	(202,128)
CASH FLOWS FROM INVESTING ACTIVITIES:
Investment in patents	(4,969)	(54,930)
Net cash used by investing activities	(4,969)	(54,930)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible notes payable	0	180,100
Payments on convertible notes	0	(24,650)
Net cash provided by financing activities	0	155,450
NET INCREASE (DECREASE) IN CASH	(691)	(70,886)
CASH, beginning of period	1,210	72,294
CASH, end of period	519	1,408
Noncash investing and financing activities for the quarter ending
Stock issued for convertible notes payable and accrued interest	132,276	232,535
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid in cash	0	0
Taxes paid in cash	$ 0	$ 0